Abstract
Background: Fiberoptic bronchoscopy (FOB) is standard as a pre-eminent technique for diagnostic, palliative, and curative purposes in variable pulmonary insults.
Objectives: The objectives of this study were to identify the causation, technical aspects, pathophysiological impacts, and complications of FOB in critically ill patients, to anticipate predictors of mortality in critically ill patients who underwent FOB.
Patients and Methods: This prospective cohort study was carried out in ICUs on 52 critically ill patients who were subjected to FOB for diagnostic or therapeutic purposes. They were grouped into the mechanical ventilation (MV) (28/52) and non-MV (24/52) groups. FOB outcomes and complications were encountered.
Results: FOB had a particular indication in management of 12/52 cases (13.6%) for both pneumonic and inhalation lung injury cases, 10/52 (19.2%) for underlining focal lung lesion, 8/52 (15.4%) for hemoptysis, and 5/52 (9.6%) for either acute respiratory distress syndrome or atelectasis condition. There was a highly considerable variation between the MV and non-MV groups. FOB outcomes were as follows: 31/52 (59.6%) cases improved, 11/52 (21.2%) died, and 10/52 (19.2%) were referred to a tertiary health unit. There were significant negative correlations between outcomes and reasons for admission, time of onset of FOB, and radiological pattern. Older age, respiratory insult, immune-compromised state, non-ventilator assessment, and less frequency of FOB performance were predictors of mortality among critically ill patients who underwent FOB.
Footnotes
Cite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 2836.
This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.
This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).
- Copyright ©the authors 2020